A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT00622258 · COMPLETED
Trial details
- NCT number
- NCT00622258
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2014-01-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.